Steven R. LaPorte

RITA Medical Systems, Inc. develops, manufactures and markets ablation technology products used by physicians to treat patients with solid cancerous or benign tumors. The system consists of a radiofrequency energy generator and disposable accessories. The RITA systems have been approved to treat liver cancer and are sold in Asia, Europe and the US. The company develops the use of the system for the treatment of various other cancers. Investors in RITA Medical include Apax Partners and Morgan Stanley. RITA Medical is in the process of merging with Horizon Medical. RITA Medical Systems has been acquired by Angio Dynamics, inc. The company was founded in 1994 and is headquartered in Fremont, CA.

ONSET Ventures service corporation (ONSET Ventures service ) is a venture capital firm founded in 1984 by Terry Opdendyk and Michael James Levinthal. The firm is headquartered in Menlo Park, California.

IntElect Medical, Inc. provided health care services. The firm developed therapies for the recovery of chronic strokes and traumatic brain injuries. The company was founded in April 2005 and was headquartered in Marlborough, MA.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ.

Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.

NeuroAccess Technologies, Inc. develops spinal cord stimulation therapies and technologies for chronic pain patients who are failed candidates for traditional chronic SCS implant procedures. The company was founded by Vince P. Owens, Scott Kokones, Nandan Lad, Greg Schulte, and Andrew D. Firlik in 2012 and is headquartered in Boston, MA.